Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · OVG

Magnetic Cell Selection System For Cd34+ Cells From Hpc-Apheresis Used In Treatment Of Acute Myeloid Leukemia (Aml)

For processing hematopoietic progenitor cells-apheresis (HPC-A) from an HLA-identical donor to obtain a CD34 positive cell enriched population that will provide for hematopoietic reconstitution following a myeloablative preparative regimen without the need for additional graft-vs-host disease (GVHD) prophylaxis.

Product / regulatory recordCompanyPathwayDecision dateSource

No records match this search

Try a device name, company name or regulatory identifier.

Source information

Follow the FDA links to view the original records.

All device categories